Prognostic Significance of Absolute Lymphocyte Count (ALC) and Lymphodepletion (LD) Regimen in Chimeric Antigen Receptor T-cell Therapy (CAR T)

Key Points

• The absolute lymphocyte count is significantly related to treatment outcomes in CAR T therapies, influencing prognosis.
• Data suggests that patients with higher lymphocyte counts experience better overall survival rates, enhancing treatment efficacy.
• Analysis of lymphodepletion regimens across multiple patient cohorts indicates variability in response rates, altering therapeutic strategies.
• Understanding lymphocyte behavior in CAR T therapy is crucial for optimizing treatment plans and navigating patient care effectively.